Zobrazeno 1 - 10
of 505
pro vyhledávání: '"M. Allen"'
Autor:
Charmaine E. Lok, Petra Macaskill, Michael J. Bourke, Richard D. M. Allen, Germaine Wong, Allison Tong, Anh Kieu, Jeremy R. Chapman, Antoni Castells, Shaundeep Sen, Armando Teixeira-Pinto, Jean Y. Yang, Jonathan C. Craig, Carol A. Pollock, Nicholas B Cross, Steven J. Chadban, Wai H. Lim, Eric Au, Laura J James, Fritz Diekmann, Kirsten Howard, Simon D. Roger, Robin M. Turner
Publikováno v:
American Journal of Kidney Diseases. 79:549-560
The risk of developing colorectal cancer in patients with chronic kidney disease (CKD) is twice that of the general population, but the factors associated with colorectal cancer are poorly understood. The aim of this study was to identify factors ass
Autor:
Harry J. de Koning, Ivica Grgurević, Patrick S. Kamath, Laurent Castera, Emmanuel Tsochatzis, Frank Lammert, Isabel Graupera, Ann T. Ma, Núria Fabrellas, Dominique Roulot, Pere Ginès, Mª Alba Diaz, Salvador Augustin, Andrea Martini, Vincent Wai-Sun Wong, Judit Pich, Rosa Maria Morillas, Philip N. Newsome, Miquel Serra-Burriel, Maja Thiele, Aleksander Krag, Phillipp Hartmann, Robert J. de Knegt, Michael P Manns, Montserrat García-Retortillo, Jörn M. Schattenberg, Indra Neil Guha, Alina M. Allen, Llorenç Caballería
Publikováno v:
Scientia
Hepatology
Ginès, P, Castera, L, Lammert, F, Graupera, I, Serra-Burriel, M, Allen, A M, Wong, V W-S, Hartmann, P, Thiele, M, Caballeria, L, de Knegt, R J, Grgurevic, I, Augustin, S, Tsochatzis, E A, Schattenberg, J M, Guha, I N, Martini, A, Morillas, R M, Garcia-Retortillo, M, de Koning, H J, Fabrellas, N, Pich, J, Ma, A T, Diaz, M A, Roulot, D, Newsome, P N, Manns, M, Kamath, P S, Krag, A & LiverScreen Consortium Investigators 2022, ' Population screening for liver fibrosis : Toward early diagnosis and intervention for chronic liver diseases ', Hepatology, vol. 75, no. 1, pp. 219-228 . https://doi.org/10.1002/hep.32163
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Hepatology
Ginès, P, Castera, L, Lammert, F, Graupera, I, Serra-Burriel, M, Allen, A M, Wong, V W-S, Hartmann, P, Thiele, M, Caballeria, L, de Knegt, R J, Grgurevic, I, Augustin, S, Tsochatzis, E A, Schattenberg, J M, Guha, I N, Martini, A, Morillas, R M, Garcia-Retortillo, M, de Koning, H J, Fabrellas, N, Pich, J, Ma, A T, Diaz, M A, Roulot, D, Newsome, P N, Manns, M, Kamath, P S, Krag, A & LiverScreen Consortium Investigators 2022, ' Population screening for liver fibrosis : Toward early diagnosis and intervention for chronic liver diseases ', Hepatology, vol. 75, no. 1, pp. 219-228 . https://doi.org/10.1002/hep.32163
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Population screening; Liver fibrosis; Early diagnosis Cribratge de població; Fibrosi hepàtica; Diagnòstic precoç Cribado de población; Fibrosis hepática; Diagnóstico precoz Cirrhosis, highly prevalent worldwide, develops after years of hepatic
Publikováno v:
Gastroenterology. 161:1630-1656
Autor:
Jake Gundrum, Linda D. Gillam, Sharon L. Mulvagh, Nancy M. Allen LaPointe, Michael L. Main, Julia Weleski Fu
Publikováno v:
The American Journal of Cardiology. 150:117-122
Limited data suggests ultrasound enhancing agent (UEA) use is associated with changes in clinical management and lower mortality in intensive care unit (ICU) patients. We conducted a retrospective observational study to determine if contrast echocard
Autor:
Vanessa Blumer, Fatima Ali-Ahmed, Frederik Dalgaard, Andrzej S. Kosinski, Daniel P. Morin, Gillian D Sanders, Nancy M. Allen LaPointe, Sana M. Al-Khatib
Publikováno v:
Prog Cardiovasc Dis
Background: Cardiac resynchronization therapy (CRT) has been demonstrated to improve heart failure (HF) symptoms, reverse LV remodeling, and reduce mortality and HF hospitalization (HFH) in patients with a reduced left ventricular (LV) ejection fract
Autor:
Daniel Okin, Jocelyn R. Farmer, Gabriel E. Molina, Michael Dougan, Yonina R. Murciano-Goroff, Aditya Bardia, Steven T. Chen, Benjamin D. Medoff, Rebecca Karp Leaf, Meghan J. Mooradian, Ian M. Allen, Alexander T. Faje, Tomas G. Neilan, Minh Mai, Sara R. Schoenfeld, Meghan E. Sise, Molly Thomas, Daniel A. Zlotoff, Leyre Zubiri, Kerry L. Reynolds, Yevgeniy R. Semenov, Minna J. Kohler, Mazen Nasrallah, Amanda C. Guidon, Justine V. Cohen, Michelle Rengarajan, Ryan J. Sullivan, Laura A. Petrillo, Sienna Durbin, Alexandra-Chloé Villani
Publikováno v:
Oncologist
Background The aim of this study was to characterize severe immune-related adverse events (irAEs) seen among hospitalized patients and to examine risk factors for irAE admissions and clinically relevant outcomes, including length of stay, immune chec
Publikováno v:
Hepatology (Baltimore, Md.)
Background and Aims Whether glycemic control, as opposed to diabetes status, is associated with the severity of NAFLD is open for study. We aimed to evaluate whether degree of glycemic control in the years preceding liver biopsy predicts the histolog
Autor:
Sheau-Chiann Chen, Ryan M. Allen, Michelle J. Ormseth, Qiong Wu, Paolo Raggi, C. Michael Stein, Annette Oeser, Quanhu Sheng, Fei Ye, Joseph F. Solus, Kasey C. Vickers
Publikováno v:
Clin Rheumatol
MicroRNAs (miRNAs) regulate gene expression and are disease biomarkers. Rheumatoid arthritis (RA) patients have accelerated atherosclerosis leading to excess cardiovascular morbidity and mortality, but traditional risk factors for cardiovascular risk
Autor:
Elizabeth Dudnik, Aaron M. Allen, Oded Icht, Inbar Finkel, Daniel Reinhorn, Daniel A. Goldstein, Alona Zer, Oded Jacobi, Yosef Landman, Michal Sternschuss, Ofer Rotem
Publikováno v:
Oncology. 99:555-561
Introduction: Immune checkpoint inhibitors (ICI) are the new standard therapy in patients with metastatic NSCLC (mNSCLC). Metformin, previously associated with improved chemotherapy efficacy in diabetic and nondiabetic cancer patients, was recently a
Autor:
Richard D. M. Allen, Eric Au, Jean Yee Hwa Yang, Petra Macaskill, Narelle Williams, Germaine Wong, Allison Tong, Laura J James, Armando Teixeira-Pinto, Charmaine E. Lok, Steven J. Chadban, Simon D. Roger, Wai H. Lim, Robin M. Turner, Kirsten Howard, Anna Francis, Jeremy R. Chapman, Antoni Castells, Jonathan C. Craig, Shaundeep Sen, Carol A. Pollock, Anoushka Krishnan, Fritz Diekmann, Michael J. Bourke, Anh Kieu, Nicholas B Cross, Gabrielle Williams
Publikováno v:
Kidney International Reports
Introduction People with chronic kidney disease (CKD) experience reduced quality of life (QoL) because of the high symptom and treatment burden. Limited data exist on the factors associated with overall and domain-specific QoL across all CKD stages.